NCT02795858 2025-02-19
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Dana-Farber Cancer Institute
Phase 2 Completed
Clinical Trials
5 trialsNCT02973204 2021-04-28
Circulating Tumor Cells and Tumor DNA in HCC and NET
University of Aarhus
Completed
NCT02351128 2017-10-18
PHRC-Merkel
University Hospital, Grenoble
Phase 2 Completed
NCT00495846 2009-08-17
SS-HCC
Federico II University
Phase 2/3 Completed
NCT00627796 2008-03-03
ATG1line
Federico II University
Phase 4 Completed